Results 81 to 90 of about 248 (96)

Facile Synthesis of Oxazolidinones as Potential Antibacterial Agents. [PDF]

ChemistryOpen
Els SP, Govender KB, Sokhela MK, Bhatt N, Reddy N, Kruger HG, Arvidsson PI, Gunosewoyo H, Govender T, Naicker T.   +9 more
europepmc   +1 more source

[Research and International Cooperation for Shortening the Treatment Duration of Tuberculosis]. [PDF]

Jugan Geongang Gwa Jilbyeong
Jeon SM, Kim TH, Lee S, Kim S.
europepmc   +1 more source

Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China. [PDF]

Antimicrob Agents Chemother, 2018
Zong Z, Jing W, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H, Pang Y.   +9 more
europepmc   +1 more source

[Research Trends in Nontuberculous Mycobacterial Treatment]. [PDF]

Jugan Geongang Gwa Jilbyeong
Park S, Choi S, Jeon SM, Kim S.
europepmc   +1 more source

Příprava a studium antituberkuloticky účinných látek ze skupiny dusíkatých heterocyklů [PDF]

, 2018
Roh, Jaroslav
core  

Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. [PDF]

Nat Rev Drug Discov
Dartois V, Dick T.
europepmc   +1 more source

Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review. [PDF]

GMS Hyg Infect Control
Michalik M, Lorenc T, Marcinkowski K, Muras M, Mikszta N, Mikszta J, Kantor K, Marcinkowska J.   +7 more
europepmc   +1 more source

Antibacterials with Novel Chemical Scaffolds in Clinical Development. [PDF]

Drugs
Heimann D, Kohnhäuser D, Kohnhäuser AJ, Brönstrup M.   +3 more
europepmc   +1 more source

First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of Tuberculosis. [PDF]

JAC Antimicrob Resist
Lutchmun W, Heinrich N, Svensson EM, Kloss F, Konsten S, Dreisbach J, Hoelscher M.   +6 more
europepmc   +1 more source